Select Page

New Graphene Flagship “Spearhead Projects” get €92 million in funding

The Graphene Flagship has announced the launch of eleven new “Spearhead Projects”, each developed to take graphene-enabled prototypes to commercial applications. Now, the Graphene Flagship has committed €45 million to invest in eleven commercialization...
NanoEDGE: German-Israeli collaboration to develop wearable electronics for mental disorder diagnosis and functional restoration

NanoEDGE: German-Israeli collaboration to develop wearable electronics for mental disorder diagnosis and functional restoration

The NanoEDGE BMBF-Project, coordinated by the Fraunhofer Institute for Biomedical Engineering IBMT, aims at the development of a graphene-based ink for inkjet printing and a scalable printing process as well as a resource-efficient process chain for the production of...
Archer Materials’ graphene ink formulations printed and tested with prototype device

Archer Materials’ graphene ink formulations printed and tested with prototype device

Archer Materials (formerly Archer Exploration) has reported progressing its graphene-based biosensor technology development by building a first-phase prototype device to test the printing and performance of graphene inks.The prototype biosensor technology built at the...
Graphene-based nanosensor detects microscopic contaminants in water

Graphene-based nanosensor detects microscopic contaminants in water

Researchers from Iowa State University’s (ISU) Department of Mechanical Engineering, led by Dr. Jonathan Claussen, have developed a graphene-enhanced sensor that can detect organophosphates at levels 40 times smaller than the U.S. Environmental Protection Agency (EPA)...
Graphene and gold sensing platform may help fight neurological disorders

Graphene and gold sensing platform may help fight neurological disorders

A Rutgers University-led team has created what it is calling a “better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer’s and Parkinson’s diseases and other neurological disorders”.The development, which is based...

Cardea Bio and Nanosens Innovations merger-acquisition finalized

Cardea Bio (formerly: Nanomedical Diagnostics) and Nanosens Innovations have joined forces to accelerate the development of the Genome Sensor: the world’s first DNA search engine that runs on CRISPR-Chip technology.Cardea has announced the finalization of their...